Free Trial

Reviva Pharmaceuticals (RVPHW) Competitors

$0.21 0.00 (0.00%)
(As of 11/22/2024 ET)

RVPHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Reviva Pharmaceuticals stock or one of its competitors? The main competitors of Reviva Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Reviva Pharmaceuticals vs.

180 Life Sciences (NASDAQ:ATNFW) and Reviva Pharmaceuticals (NASDAQ:RVPHW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Reviva PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Reviva Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Reviva Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Reviva Pharmaceuticals N/A N/A N/A

180 Life Sciences and Reviva Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Reviva PharmaceuticalsN/AN/A

Summary

180 Life Sciences and Reviva Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVPHW vs. The Competition

MetricReviva PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$121.47M$5.21B$8.81B
Dividend YieldN/A3.64%5.54%4.07%
P/E RatioN/A153.5394.7617.73
Price / SalesN/A19,352.331,207.8590.18
Price / CashN/A12.5541.7436.95
Price / BookN/A8.547.246.54
Net IncomeN/A-$20.42M$119.96M$226.07M
7 Day Performance9.10%0.54%2.14%3.77%
1 Month Performance71.26%8.89%-2.24%4.46%
1 Year Performance-80.25%31.79%32.76%27.57%

Reviva Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVPHW
Reviva Pharmaceuticals
N/A$0.21
flat
N/A-81.1%$0.00N/A0.005
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+7.4%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
flat
N/A-15.0%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.06
-10.0%
N/AN/A$0.00$391.87M0.004Gap Down
ALVO
Alvotech
2.1312 of 5 stars
$12.44
+0.2%
$18.00
+44.7%
+31.4%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+71.4%$0.00N/A0.004Gap Down
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.07
+18.2%
N/AN/A$0.00$35.36M0.0070
BTMDW
biote
N/A$0.50
flat
N/A-53.3%$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:RVPHW) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners